Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

ReQuip effective in restless legs syndrome

March 4, 1999

Biochemical and pharmacological profile of new MAO-A inhibitor: 2614W94

March 3, 1999

Alertec approved in Canada for treatment of narcolepsy

March 3, 1999

Janssen confirms lubeluzole no longer under development

March 3, 1999

FDA issues complete response letter for Rebif BLA

March 3, 1999

German launch announced for Merck's migraine drug

March 2, 1999

Chirocaine considered approvable by FDA, rights return to Chiroscience

March 2, 1999

Favorable phase I results reported for GT-2331 as single doses

March 2, 1999

AHP describes new dopamine autoreceptor agonists in patent literature

March 2, 1999

Orion signs licensing agreement with R.P. Scherer for Zydis apomorphine

March 2, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...